Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axillary block plus subcutaneous local anesthetic for tourniquet pain relief
IRCT20131108015322N6Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ropivacaine, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: tourniquet pain intensity. Started Jan 2022; status: completed.
02
Drugs
ropivacaine
Beyond the preview
Go deeper on IRCT20131108015322N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131108015322N6.